Pemvidutide 2.4 mg delivered a statistically significant and clinically meaningful reduction in heavy drinking days, the primary endpoint of the trial Important secondary endpoints were also met, incl ...

Based on these data, Altimmune plans to request an End-of-Phase 2 (EOP2) meeting with the FDA to discuss the path forward for pemvidutide in AUD. Results from the RECLAIM trial will be submitted for ...

An 82-year-old Minnesota resident helped win a change to state alcohol regulations after arguing that seniors living in assisted living communities should still be able to enjoy social gatherings ...

HEINEKEN USA has announced a first-of-its-kind partnership with OpenTable, enabling diners to designate a driver directly in the booking process. Rooted in HEINEKEN USA's There's No Such Thing As Fine ...

Napa-based Intervine CEO Jonjie Lockman says airline and cruise ship passengers aren’t cutting back on wine and beer ...